The U.S. Food and Drug Administration approved a new drug on Friday that reduces the complications associated with sickle cell disease — the first drug approved for the blood disorder in more than 20 years.
The drug, called Endari, consists of L-glutamine, which is an amino acid, and is approved for sickle cell patients five years and older.
Read Next
